ACE and COVID-19: The BRACE CORONA (blockers of angiotensin receptor and angiotensin‐converting enzyme inhibitors suspension in hospitalized patients with coronavirus infection) randomized trial7 in patients hospitalized with mild–moderate COVID‐19 suggested that days alive outside of hospital were equivalent in those continuing ACEIs/ARBs compared with those who had therapy suspended.